Sign in

CIK 0001631574

  • Large accelerated filer

Wave Life Sciences, Inc.

Sign in to watch
Ticker
WVE
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 617-949-2900
Business address
733 CONCORD AVENUE, CAMBRIDGE, MA, 02138
Former names
Wave Life Sciences Ltd., Wave Life Sciences LTD., WAVE Life Sciences Ltd., Wave Life Sciences Pte Ltd
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 45 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-01 Vargeese Chandra Chief Technology Officer Grant or award · Share Option (right to buy) +200,000 200,000
2021-08-16 RA CAPITAL MANAGEMENT, L.P. Director Grant or award · Share Option (right to buy) +42,000 42,000
2021-08-16 Wagner Heidi L Director Grant or award · Share Option (right to buy) +21,000 21,000
2021-08-16 Verdine Gregory L. Director Grant or award · Share Option (right to buy) +42,000 42,000
2021-08-16 TAKANASHI KEN Director Grant or award · Share Option (right to buy) +42,000 42,000
2021-08-16 Rawcliffe Adrian Director Grant or award · Share Option (right to buy) +42,000 42,000
2021-08-16 CORRIGAN MARK Director Grant or award · Share Option (right to buy) +21,000 21,000
2021-08-16 HENRY CHRISTIAN O Director Grant or award · Share Option (right to buy) +42,000 42,000
2021-08-16 Tan Aik Na Director Grant or award · Share Option (right to buy) +21,000 21,000
2021-04-01 RA CAPITAL MANAGEMENT, L.P. Director Other acquisition +201,594 $5.61 $1.1M 201,594
2021-04-01 RA CAPITAL MANAGEMENT, L.P. Director Other acquisition +768,431 $5.61 $4.3M 7,573,613
2021-03-24 Moran Kyle Chief Financial Officer Exercise or conversion +10,930 $2.48 $27K 80,792
2021-03-24 Moran Kyle Chief Financial Officer Exercise or conversion · Share Option (right to buy) −10,930 25,000
2021-02-16 Francis Chris Sale −2,698 $10.57 $29K 78,462
2021-02-16 BOLNO PAUL President and CEO Sale −11,205 $10.57 $118K 410,976
2021-02-16 Panzara Michael A. Sale −2,929 $10.57 $31K 86,420
2021-02-16 Vargeese Chandra Chief Technology Officer Sale −3,145 $10.57 $33K 85,412
2021-02-16 Moran Kyle Chief Financial Officer Sale −1,722 $10.57 $18K 69,862
2021-02-01 Francis Chris Grant or award +50,000 81,160
2021-02-01 Francis Chris Grant or award · Share Option (right to buy) +50,000 50,000

Page 15 of 22 · 433 trades